{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"12.350","floor":"8.880"},"ipodate":{"start":"2017-09-05 00:00:00","end":"2017-09-08 00:00:00"},"minimumcapital":"4989.78","subscribed":"17.58","marketcap":"35.85億","H_marketcap":"--","pe":"57.51","codesrate":"100.00","link":"https://staticpdf.iqdii.com/stockdata/notice/Prospectus/01696/LTN20170905014_C.pdf","ipopricing":"8.880","resultdate":"2017-09-18 00:00:00","enddate":"2017-09-08 00:00:00","listeddate":"2017-09-19 00:00:00","issuenumber":"11000.00萬","issuenumberhK":"3300.00萬","issuenumberother":"7700.00萬","grayprice":"8.77","sponsors":"中國國際金融香港證券有限公司,富瑞金融集團香港有限公司","raisemoney":"68870.00萬","use":"1、約18.6%，或約128.4百萬港元，預期用于擴展我們的銷售渠道及分銷網絡以及加強我們的營銷力度；\n2、約18.6%，或約128.4百萬港元，用于資本開支； \n3、約14.0%，或約96.3百萬港元，預期用于研究及開發活動； \n4、約9.3%，或約64.2百萬港元，預期將用于償還關聯方復星實業（香港）有限公司的收購貸款； \n5、約29.5%，或約202.5百萬港元，預期將用于策略性收購、設立戰略合作關系，以及其他業務發展；\n6、約10.0%，或約68.9百萬港元，預期用作營運資金及一般公司用途。","shares":400,"leadagent":"中國國際金融香港證券有限公司,富瑞金融集團香港有限公司,復星恒利證券有限公司,海通國際證券有限公司,華泰金融控股(香港)有限公司","bookrunners":"中國國際金融香港證券有限公司,富瑞金融集團香港有限公司,復星恒利證券有限公司,海通國際證券有限公司,華泰金融控股(香港)有限公司","coordinator":"中國國際金融香港證券有限公司,富瑞金融集團香港有限公司,復星恒利證券有限公司","firstDayOpen":"8.79","IsEiio":0,"Interestdays":10,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"中國國際金融香港證券有限公司","code":"E01696","name":"SISRAM MED","fullname":"Sisram Medical Ltd"},"institutioninfo":{"principaloffice":"以色列凱撒利亞工業區Halamish大街14號","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628","chairman":"劉毅","secretary":"甘美霞","telephone":"(972) 4 6275357","substantialshareholders":"上海復星醫藥(集團)股份有限公司(52.83%),復星－保德信中國機會基金(有限合伙)(21.93%)","principalactivities":"集團是全球領先的能量源醫療美容器械供貨商，具有自主設計、研發及生產能力。","website":"http://www.sisram-medical.com"},"managerinfo":[{"managername":"劉毅","post":"主席兼執行董事","rankno":1},{"managername":"Lior Moshe DAYAN","post":"首席執行官兼執行董事","rankno":2},{"managername":"吳以芳","post":"非執行董事","rankno":3}],"investorinfo":[{"institutionname":"上海自貿試驗區一期股權投資基金合伙企業(有限合伙)","shareholding":"13,175,600.0","percentage":2.99,"ReleaseDate":"2018-03-19 00:00:00","relatedparty":"上海機場(集團)有限公司","subsidiary":["上海自貿試驗區一期股權投資基金合伙企業(有限合伙)"],"InverstorType":"公司"},{"institutionname":"升泰有限公司","shareholding":"8,783,600.0","percentage":2,"ReleaseDate":"2018-03-19 00:00:00","relatedparty":"Siu Muk CHAN","subsidiary":["升泰有限公司"],"InverstorType":"公司"},{"institutionname":"紐頓醫學美容集團有限公司","shareholding":"3,337,600.0","percentage":0.76,"ReleaseDate":"2018-03-19 00:00:00","relatedparty":"林明盛","subsidiary":["紐頓醫學美容集團有限公司"],"InverstorType":"公司"}],"TotalShareholdingPercentage":5.75},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":512}